Literature DB >> 18580215

Visceral injury and systemic inflammation in patients undergoing extracorporeal circulation during aortic surgery.

Sebastiaan J Hanssen1, Joep P Derikx, Iris C Vermeulen Windsant, John H Heijmans, Thomas A Koeppel, Geert Willem Schurink, Wim A Buurman, Michael J Jacobs.   

Abstract

OBJECTIVES: Visceral injury and inflammation are evaluated in patients undergoing extracorporeal circulation (ECC) either with distal aortic perfusion (DAP) during thoracic aortic aneurysm (TAA) repair or DAP and selective organ perfusion (DAP and SP) during thoracoabdominal aortic aneurysm (TAAA) repair. SUMMARY BACKGROUND DATA: Visceral hypoperfusion and subsequent visceral injury, mainly to the gut, have been implicated as central events in the development of systemic inflammatory response syndrome (SIRS) and organ dysfunction after major surgery. Patients undergoing DAP or DAP and SP are exposed to artificial visceral perfusion, potentially leading to the development of intestinal injury and systemic inflammation.
METHODS: To assess visceral injury arteriovenous differences of fatty acid binding proteins were measured for the gut (I-FABP and L-FABP) and left kidney (L-FABP) along with systemic plasma concentrations. Systemic ALT was used as liver injury marker. Plasma IL-6 and IL-8 denoted systemic inflammation.
RESULTS: During ECC systemic I-FABP and L-FABP levels increased in both groups, representing intestinal injury. Significantly elevated levels of I-FABP (P < 0.001) and L-FABP (P < 0.001) were found in the DAP and SP group, after ECC was stopped and normal circulation restored. Liver and renal tubular cell injury was not detected. Significant increases in systemic IL-6 and IL-8 values were measured only in patients undergoing DAP and SP. Additionally, the extent of intestinal injury correlated positively with systemic inflammation.
CONCLUSIONS: This study shows the development of intestinal mucosal injury during ECC with DAP or DAP and SP, indicative of insufficient intestinal perfusion. Intestinal injury was associated with a systemic pro-inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18580215     DOI: 10.1097/SLA.0b013e3181784cc5

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  25 in total

1.  Non-invasive markers of gut wall integrity in health and disease.

Authors:  Joep P M Derikx; Misha D P Luyer; Erik Heineman; Wim A Buurman
Journal:  World J Gastroenterol       Date:  2010-11-14       Impact factor: 5.742

2.  Non-invasive assessment of barrier integrity and function of the human gut.

Authors:  Joep Grootjans; Geertje Thuijls; Froukje Verdam; Joep Pm Derikx; Kaatje Lenaerts; Wim A Buurman
Journal:  World J Gastrointest Surg       Date:  2010-03-27

3.  Quantitative Measure of Intestinal Permeability Using Blue Food Coloring.

Authors:  Stephanie A K Angarita; Sergio Duarte; Tara A Russell; Piotr Ruchala; Irmina A Elliott; Julian P Whitelegge; Ali Zarrinpar
Journal:  J Surg Res       Date:  2018-07-27       Impact factor: 2.192

4.  Human intestinal ischemia-reperfusion-induced inflammation characterized: experiences from a new translational model.

Authors:  Joep Grootjans; Kaatje Lenaerts; Joep P M Derikx; Robert A Matthijsen; Adriaan P de Bruïne; Annemarie A van Bijnen; Ronald M van Dam; Cornelis H C Dejong; Wim A Buurman
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

5.  Impact of serum high-mobility group box 1 protein elevation on oxygenation impairment after thoracic aortic aneurysm repair.

Authors:  Takashi Kohno; Toshihisa Anzai; Hideyuki Shimizu; Hidehiro Kaneko; Yasuo Sugano; Shingo Yamada; Tsutomu Yoshikawa; Akitoshi Ishizaka; Ryohei Yozu; Satoshi Ogawa
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

6.  Diagnosis of ischemic small bowel disease by measurement of serum intestinal fatty acid-binding protein in patients with acute abdomen: a multicenter, observer-blinded validation study.

Authors:  Tatsuo Kanda; Akihiro Tsukahara; Kyo Ueki; Yasuo Sakai; Tatsuo Tani; Atsushi Nishimura; Toshiyuki Yamazaki; Yoichi Tamiya; Tetsuya Tada; Masaki Hirota; Jun Hasegawa; Hiroyuki Funaoka; Hiroshi Fujii; Katsuyoshi Hatakeyama
Journal:  J Gastroenterol       Date:  2011-02-05       Impact factor: 7.527

7.  Cytokine balance in hepatosplanchnic system during thoracoabdominal aortic aneurysm repair.

Authors:  Takashi Kunihara; Suguru Kubota; Norihiko Shiiya; Kenji Iizuka; Shigeyuki Sasaki; Satoru Wakasa; Kenji Matsuzaki; Yoshiro Matsui
Journal:  J Artif Organs       Date:  2011-06-24       Impact factor: 1.731

Review 8.  State-of the-art review on the renal and visceral protection during open thoracoabdominal aortic aneurysm repair.

Authors:  Karl Waked; Marc Schepens
Journal:  J Vis Surg       Date:  2018-02-08

9.  Upregulation of TLR2/4 expression in mononuclear cells in postoperative systemic inflammatory response syndrome after liver transplantation.

Authors:  Ziqing Hei; Xinjin Chi; Nan Cheng; Gangjian Luo; Shangrong Li
Journal:  Mediators Inflamm       Date:  2010-06-16       Impact factor: 4.711

Review 10.  Cytokines as biomarkers of inflammatory response after open versus endovascular repair of abdominal aortic aneurysms: a systematic review.

Authors:  Diamantis I Tsilimigras; Fragiska Sigala; Georgios Karaolanis; Ioannis Ntanasis-Stathopoulos; Eleftherios Spartalis; Michael Spartalis; Nikolaos Patelis; Alexandros Papalampros; Chandler Long; Demetrios Moris
Journal:  Acta Pharmacol Sin       Date:  2018-05-17       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.